Enrofloxacin monohydrochloride
CAS: 93106-59-3
Rif. 3D-TDA10659
| 250mg | Fuori produzione | ||
| 2500mg | Fuori produzione |
Informazioni sul prodotto
Nome:
Enrofloxacin monohydrochloride
Sinonimi:
- 3-Quinolinecarboxylicacid, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-,monohydrochloride (9CI)
Descrizione:
Enrofloxacin monohydrochloride is a medicinal product that acts as a protein kinase inhibitor. It has been shown to inhibit the growth of cancer cells, including leukemia cells, by inducing apoptosis and cell cycle arrest. Enrofloxacin monohydrochloride has been tested in Chinese hamster ovary cells and found to be effective in inhibiting tumor growth. This drug is excreted mainly through urine and has been shown to have anticancer properties due to its ability to inhibit protein kinases involved in cancer cell proliferation. Enrofloxacin monohydrochloride is a promising therapeutic option for the treatment of various types of cancer in humans.
Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:
Proprietà chimiche
Peso molecolare:
395.9 g/mol
Formula:
C19H23ClFN3O3
Purezza:
Min. 95%
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:
